https://www.selleckchem.com/pr....oducts/s-gsk1349572.
demographics were not significantly different among survivors and nonsurvivors by Fisher's exact test. Conclusion In COVID-19 patients treated with tocilizumab, IL-6 levels are significantly elevated, which are supportive of cytokine storm. Following initiation of tocilizumab, there is elevation in the IL-6 levels and CRP levels dramatically decrease, suggesting an improvement in this hyperinflammatory state. Ongoing randomized control trials will allow for further evaluation of this promising therapy. Importance Recent data indica
Like
Comment
Share
